These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3666972)

  • 1. Cystic fibrosis. Part I.
    Infection; 1987; 15(4):269-312. PubMed ID: 3666972
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic fibrosis lung disease: interplay of a microbial microcosm and extremes of inflammation.
    Blau H
    Isr Med Assoc J; 2006 Jan; 8(1):58-9. PubMed ID: 16450756
    [No Abstract]   [Full Text] [Related]  

  • 3. First isolations of Segniliparus rugosus from patients with cystic fibrosis.
    Butler WR; Sheils CA; Brown-Elliott BA; Charles N; Colin AA; Gant MJ; Goodill J; Hindman D; Toney SR; Wallace RJ; Yakrus MA
    J Clin Microbiol; 2007 Oct; 45(10):3449-52. PubMed ID: 17670929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection].
    Thumerelle C
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation of Scedosporium prolificans in patients with cystic fibrosis].
    García E; Rodríguez V; Gartner S; Gené J
    Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):488-9. PubMed ID: 9918999
    [No Abstract]   [Full Text] [Related]  

  • 7. Burkholderia cepacia in cystic fibrosis.
    LiPuma JJ; Stull TL
    N Engl J Med; 1995 Mar; 332(12):820; author reply 820-1. PubMed ID: 7532286
    [No Abstract]   [Full Text] [Related]  

  • 8. Difficult bacteria, antibiotic resistance and transmissibility in cystic fibrosis.
    Elborn JS
    Thorax; 2004 Nov; 59(11):914-5. PubMed ID: 15516459
    [No Abstract]   [Full Text] [Related]  

  • 9. Nocardia farcinica isolated from bronchoalveolar lavage fluid of a child with cystic fibrosis.
    Petersen BE; Jenkins SG; Yuan S; Lamm C; Szporn AH
    Pediatr Infect Dis J; 2007 Sep; 26(9):858-9. PubMed ID: 17721390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia--a transmissible cystic fibrosis pathogen.
    Burns JL
    J Pediatr; 2001 Nov; 139(5):618-9. PubMed ID: 11713434
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.
    Van Devanter DR
    Respiration; 2007; 74(3):356; author reply 357. PubMed ID: 17204830
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspergillus organisms in patients with cystic fibrosis.
    Taccetti G; Campana S; Marianelli L
    Pediatr Pulmonol; 1997 Apr; 23(4):317-8. PubMed ID: 9141120
    [No Abstract]   [Full Text] [Related]  

  • 14. Burkholderia cepacia in cystic fibrosis.
    Govan JR
    N Engl J Med; 1995 Mar; 332(12):819-20; author reply 820-1. PubMed ID: 7532285
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness analysis in cystic fibrosis.
    Doran C; Vos T
    J Cyst Fibros; 2005 Dec; 4(4):211-2. PubMed ID: 16230054
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is the burden of respiratory infection in the progression of cystic fibrosis].
    Bellon G
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S49-55. PubMed ID: 12910134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mortality in cystic fibrosis].
    Koch C
    Ugeskr Laeger; 1997 Sep; 159(39):5779. PubMed ID: 9340880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.